NDLI: Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry

Please wait, while we are loading the content...

Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas usinganti-HBxAg monoclonal antibody

Vascularization pattern of c6 glioma is modified with medroxyprogesterone acetate and ibuprofen in Wistar rat brain

Significance of immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human breast cancer

Effect of Earthworm (G-90) Extract on Formation and Lysis of Clots Originated from Venous Blood of Dogs with Cardiopathies and with Malignant Tumors

Alterations in MDM2 expression in esophageal squamous cell carcinoma: Relationship with p53 status

Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer

Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: Is it helpful?

Molecular pathology of tumor metastasis : I. Predictive pathology

Pathology & Oncology Research : Volume 7, Issue 2, June 2001

Pathology & Oncology Research : Volume 7, Issue 1, March 2001

Pathology & Oncology Research : Volume 6

Pathology & Oncology Research : Volume 5

Pathology & Oncology Research : Volume 4

Pathology & Oncology Research : Volume 3

Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry

Content Provider	Springer Nature Link
Author	Esteva, Francisco J. Hortobagyi, Gabriel N. Sahin, Aysegul A. Smith, Terry L. Chin, Dot Mon Liang, Shang Ying Pusztai, Lajos Buzdar, Aman U. Bacus, Sarah S.
Copyright Year	2001
Abstract	The purpose of this study was to investigate the frequency of expression of the erbB/HER family of growth factor receptors, their ligand heregulin, and the two different signaling pathways p38 and mitogen-activated protein kinase (MAPK), as well as the status of HER-2 phosphorylation in tumor specimens from patients with primary breast cancer. The level of expression of these proteins was measured by quantitative immunohistochemistry combined with microscope-based image analysis in paraffin-embedded breast cancer tissue from 35 patients. The frequency of expression was: EGFR (51%), HER-2 (54%), P-HER-2 (48%), HER-3 (48%), HER-4 (57%), heregulin (48%), p38 (17%), MAPK (48%). There was evidence of associations among the coexpression of heregulin, EGFR, HER-2, and HER-3. Also, there was evidence of a positive association between P-MAPK and HER-4. HER-3 was expressed at high levels in patients younger than 50 years of age. There was a trend for expression of higher levels of HER-4 in tumors larger than 2 cm. The expression of EGFR, HER-2, heregulin, p38 and MAPK was independent of age, tumor size, number of lymph nodes involved or hormone receptor status. The HER family of growth factor receptors appear to be regulated independently in invasive breast cancer. Assessing the expression of multiple tumor markers by quantitative immunohistochemistry is feasible. Further research is needed to determine the prognostic and predictive roles of the various associations between HER receptors, their ligands and signal transduction molecules in patients with early-stage breast cancer.
Starting Page	171
Ending Page	177
Page Count	7
File Format	PDF
ISSN	12194956
Journal	Pathology & Oncology Research
Volume Number	7
Issue Number	3
Language	English
Publisher	Springer Netherlands
Publisher Date	2001-01-01
Publisher Place	Dordrecht
Access Restriction	Subscribed
Subject Keyword	Tumor markers, biological proto-oncogene proteins immunohistochemistry ligands breast neoplasm Cancer Research Oncology Pathology Immunology Biomedicine general
Content Type	Text
Resource Type	Article
Subject	Cancer Research Pathology and Forensic Medicine Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Expression of erbb/her receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry.

Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry

HER-2/neu overexpression in invasive ductal breast cancer: An association with other prognostic and predictive factors

Practice of HER-2 Immunohistochemistry in Breast Carcinoma in Austria

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

HER-2/neu overexpression in invasive ductal breast cancer: An association with other prognostic and predictive factors

Selected immuno-histochemical markers in curettage specimens and their correlation with final pathologic findings in endometrial cancer patients.

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.

Utility of Estrogen Receptor, Progesterone Receptor, and HER-2/neu Analysis of Multiple Foci in Multifocal Ipsilateral Invasive Breast Carcinoma

Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry

Similar Documents

Expression of erbb/her receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry.

Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry

HER-2/neu overexpression in invasive ductal breast cancer: An association with other prognostic and predictive factors

Practice of HER-2 Immunohistochemistry in Breast Carcinoma in Austria

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

HER-2/neu overexpression in invasive ductal breast cancer: An association with other prognostic and predictive factors

Selected immuno-histochemical markers in curettage specimens and their correlation with final pathologic findings in endometrial cancer patients.

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.

Utility of Estrogen Receptor, Progesterone Receptor, and HER-2/neu Analysis of Multiple Foci in Multifocal Ipsilateral Invasive Breast Carcinoma

Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry